Silo Pharma, Inc.
SILO
Revenue
18.03k
▼-1.00▼-0.005548%
3 Months ChangeAssets
8.04M
▲1.10M▲15.80%
3 Months ChangeLiabilities
2.08M
▲431.18k▲26.14%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-10
Form 8-K
ID: 0001213900-24-077111
2024-08-13
Form 10-Q
ID: 0001213900-24-068296
2024-07-22
Form 8-K
ID: 0001013762-24-000518
2024-07-08
Form 8-K
ID: 0001213900-24-059821
2024-06-27
Form 8-K
ID: 0001213900-24-056678
2024-06-06
Form 8-K
ID: 0001213900-24-050405
2024-06-04
Form 8-K
ID: 0001213900-24-049658
2024-05-13
Form 10-Q
ID: 0001213900-24-042299
2024-04-05
Form 8-K
ID: 0001213900-24-030805
2024-02-01
Form 8-K
ID: 0001213900-24-008888